H1N1 Virus: The Flu With a Pandemic on Its Record

Delhi’s H1N1 count is up almost eightfold. Here is where the virus came from, who the first patient really was, and what doctors actually prescribe.

Delhi has recorded 1,777 cases of the H1N1 virus so far this year. Over the same stretch last year it recorded 229. That is almost eight times as many, and precisely the sort of number that gets called an outbreak.

So here are the calming facts first. Nobody in the capital has died of it this year. On 23 August the Indian Council of Medical Research confirmed there is no new strain circulating. And seasonal flu, as ICMR took the trouble to point out, mostly clears up on its own.

Still. The H1N1 virus is the only flu in circulation with a pandemic on its record, and the swine flu label it picked up in 2009 has never quite come off. Worth knowing properly, then.

Where it actually came from

Not a market. Not a laboratory. From pigs, slowly, over roughly a decade.

Here is the mechanics. A flu virus keeps its genome in eight pieces, and when two strains land in the same animal those pieces get shuffled like a riffled deck. Pigs make excellent venues, their airways suiting bird flu and human flu equally well. Six of the 2009 virus’s segments traced back to a hybrid going round North American pigs since roughly 1999. Two came from a Eurasian swine lineage entirely. One pig, somewhere, hosted the lot.

Then comes the part that should worry you. Gavin Smith’s team rebuilt the family tree for Nature in June 2009 and found every gene segment had spent between nine and seventeen years out of sight. Nobody had sampled it. So the virus was not born in April 2009 at all; it had been doing the rounds of the world’s pig sheds for most of a decade first. (That jumbled ancestry, for anyone still asking, rules out a laboratory.)

The first patient, and the one everybody names instead

A California lab confirmed influenza A in a 10-year-old boy on 15 April 2009, then could not tell anyone which subtype it was. The only reason he had been swabbed is that he was enrolled in a trial of a new diagnostic test. No trial, no swab. No swab, no sequence. No sequence, no warning.

Two days on, an 8-year-old in Imperial County, 130 miles up the road. Same unrecognisable virus. The children had never met and neither had gone near a pig, which handed the CDC a conclusion nobody in that building wanted: it was already moving between people, and had been for some time.

You will often read that patient zero was Edgar Hernandez, a small boy from La Gloria in Veracruz whose stored sample tested positive weeks later. Treat that one carefully. His is the earliest confirmed case in Mexico, which is not the same as the first case anywhere. Of the thirty-odd samples taken in his village only his came back positive, and inspectors found no trace of the virus in the pig farms next door. The real first case was almost certainly someone nobody tested at all.

What followed killed between 151,700 and 575,400 people worldwide in its first year, and its signature was who it killed. Roughly 80 per cent were under 65, the reverse of an ordinary flu season. People over 60 had partial immunity from H1N1 strains circulating decades earlier. The young had none. For once, age was the advantage.

What it does to you

It arrives fast, and that is the first clue. Fine at dinner; by morning you cannot lift yourself off the mattress. Fever, chills, a sore throat, a bad head, and an ache through every muscle out of all proportion to a cough. One to four days from exposure to first symptom, then about eight days of feeling wretched. The thing worth watching is your stomach. Nausea, vomiting and loose motions turn up far more with swine flu than with the flu people know, which is why plenty of families this month have been sure somebody just ate something bad.

Most healthy people get through it unaided. The trouble is that the ones who cannot are entirely predictable, the same roster every year. The very young and the old at either end. Pregnant women. Anybody managing asthma, a heart condition, diabetes, kidney or liver trouble, or an immune system flattened by treatment. If you are on that list, this is not a virus to tough out at home. Pneumonia does the killing, and it is quick about it.

What doctors actually prescribe

Begin with the failure, because it is the instructive bit. Two older flu drugs, amantadine and rimantadine, do precisely nothing here. The reason is almost tidy. The H1N1 virus carries one mutation, S31N, sitting in exactly the protein those drugs were built to jam. One amino acid in the wrong place, and two decent medicines became ornaments. CDC dropped them from its influenza A advice altogether.

What works is a newer class. Oseltamivir, the one everybody knows as Tamiflu, does most of the heavy lifting: a tablet, twice a day, five days. Zanamivir you inhale, which rules it out for asthmatics. Peramivir goes in through a drip, useful when a patient cannot keep anything down. And baloxavir, or Xofluza, cleared in the United States in October 2018, goes after a different viral enzyme entirely and needs a single dose. That matters more than it sounds, given how many five-day courses get abandoned on day two.

Timing beats choice, though. All of them work best inside 48 hours of the first symptom. Doctors still treat later in severe cases, but that window is real and it shuts.

Two rules get broken constantly. Antibiotics do nothing to flu; they are for a bacterial infection that lands on top of it. And never give aspirin to a child or teenager with a flu-like illness, because of Reye’s syndrome, a rare brain and liver injury that kills.

For everyone else it is rest, fluids and paracetamol. Boring, and entirely sufficient.

Why families fall ill one by one

Doctors across Delhi and the NCR keep describing households going down in sequence, and there is nothing mysterious in it. You turn infectious about a day before you feel anything. So by the time the first person admits to being unwell, they have already spent a day breathing everyone else’s air over dinner. Droplets carry a couple of metres. Finer particles hang for hours in a closed, air-conditioned room, which describes most Indian homes in August.

Breaking that chain is dull work. A separate room if the house runs to one. One healthy adult as the only carer, with children, elderly relatives and pregnant women kept clear. Masks both ways. Separate plates and laundry, washed hot. Alcohol-based disinfectant twice a day on the surfaces everyone touches, because plain water will not kill a flu virus. And open a window rather than recycling the same cold air.

Flu or COVID?

You cannot tell from symptoms, and you should stop trying. Both give you fever, cough, sore throat, aches and exhaustion. The two are “difficult to distinguish based on symptoms alone”, as Dr Niraj Kumar of ShardaCare-HealthCity told NDTV this week. Flu does tend to hit abruptly where COVID-19 varies more widely, but a tendency is not a diagnosis.

It matters because the drugs do not cross over. Oseltamivir does nothing to SARS-CoV-2; nirmatrelvir-ritonavir does nothing to flu. Guess wrong and you have burnt the 48-hour window in which the right drug would have worked. Which is the entire case for testing anyone seriously ill.

The red flags, at least, are the same either way. Laboured breathing. A tight chest. Confusion, or a sleepiness nobody can rouse the patient out of. Lips or fingertips going pale. An oxygen reading that keeps sliding. Any one means hospital tonight.

So how bad is this season?

Delhi’s rise is real. Step outside it, though, and the alarm drains out of the story. Karnataka has crossed 4,000 cases with more than half in Bengaluru, which sounds ominous until you set it beside the state’s own back catalogue: 4,212 this year, 4,583 at the same point last year, 3,903 in 2024. Not a surge. A Tuesday. Mumbai, Chennai, Kolkata and parts of Kerala report more activity too, and Karnataka’s health department said out loud what public health already knew: the state gets a monsoon peak and a winter one, every year, on schedule.

The national record makes the point harder. In 2021 India logged 778 cases and 12 deaths, because masks and distancing were flattening every respiratory virus going. Take those away and it returns roaring: 13,202 cases and 410 deaths the next year, then 8,125 and 129 in 2023. By mid-2024 the tally already stood at 7,215 cases and 150 deaths, with half the year to run. Set Delhi’s 1,777 and nobody dead against that and it stops looking like an emergency. It looks like an ordinary bad monsoon, counted more carefully than usual. Case counts measure how hard a system is looking, too.

ICMR has identified the circulating virus as A/Missouri/11/2025-like, clade 6B.1A.5a2a, subclade D.3.1.1, and well matched to this season’s vaccine; India’s trivalent shot covers H1N1, H3N2 and B/Victoria. Anil Bansal of the Delhi Medical Association gave The Hindu the practical version without any drama: people at higher risk “should consider annual vaccination and seek medical advice promptly if flu symptoms become severe”. The whole public health message, in one sentence.

Which is the part worth ending on. The pandemic was declared over in August 2010. The virus was not. It slid into the seasonal rotation, it comes back every monsoon, and the vaccine that blunts it sits in clinics most of the people who need it walk straight past. Not a failure of science, that. Just a habit nobody has picked up.

Sources

• ICMR: no new H1N1 strain in India, existing vaccines sufficient — The Hindu, 23 August 2026
• ICMR on the Delhi outbreak: no cause for panic — Business Today, 23 August 2026
• H1N1 cases surge in Delhi and Bengaluru — NDTV, 24 August 2026
• H1N1 alert: how to break the chain in a household — NDTV, 24 August 2026
• Karnataka health department advisory on rising H1N1 — India TV, 24 August 2026
• Health Ministry urges early medical attention as Delhi cases rise — Outlook India
• Smith GJD et al., “Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic”, Nature, June 2009
• CDC: 2009 H1N1 pandemic summary (H1N1pdm09 virus)
• CDC: the burden of H1N1pdm09 since the 2009 pandemic
• CDC: influenza antiviral medications, guidance for clinicians
• WHO: influenza A(H1N1) outbreak
• Roche: FDA approval of Xofluza (baloxavir marboxil), 24 October 2018
• Cleveland Clinic: swine flu (H1N1)
• MedlinePlus, US National Library of Medicine: H1N1 influenza